<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00977717</url>
  </required_header>
  <id_info>
    <org_study_id>2008-05-052</org_study_id>
    <nct_id>NCT00977717</nct_id>
  </id_info>
  <brief_title>Pharmacogenomic Study to Predict Neurotoxicity of Oxaliplatin</brief_title>
  <official_title>Pharmacogenomic Study to Predict Toxicity and Response in Colorectal Cancer Patients Treated With Oxaliplatin-based Chemotherapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Samsung Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Samsung Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In order to explore genetic factors that may determine the neurotoxicity of oxaliplatin-based
      chemotherapy, germinal gene polymorphisms will be analyzed.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To investigate the impact of single nucleotide (SNP) polymorphism on the toxicity profile in
      colorectal cancer patients treated with FOLFOX chemotherapy, 10 cc of blood will be drawn in
      EDTA tube for extraction. DNA will be extracted from peripheral blood samples using DNA
      isolation kit, and SNP polymorphisms will be evaluated.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2008</start_date>
  <completion_date type="Actual">April 2010</completion_date>
  <primary_completion_date type="Actual">January 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>neuropathy</measure>
    <time_frame>six months</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Curatively Resected Stage III Colon Cancer</condition>
  <arm_group>
    <arm_group_label>FOLFOX</arm_group_label>
    <description>Stage III colorectal cancer patients who are treated with adjuvant FOLFOX chemotherapy</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      DNA will be extracted from peripheral blood samples using DNA isolation kit.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Curatively resected stage III colon cancer
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  aged 18 or older

          -  curatively resected colon adenocarcinoma

          -  pathologically staged III

          -  adequate performance status

          -  adequate major organ functions

          -  to be treated with adjuvant FOLFOX chemotherapy

          -  written informed consent

        Exclusion Criteria:

          -  those who disagree the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Se Hoon Park, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Samsung Medical Center, Seoul, Korea</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Samsung Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>135 710</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>April 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 3, 2009</study_first_submitted>
  <study_first_submitted_qc>September 14, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 16, 2009</study_first_posted>
  <last_update_submitted>April 15, 2010</last_update_submitted>
  <last_update_submitted_qc>April 15, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 19, 2010</last_update_posted>
  <responsible_party>
    <name_title>Se Hoon Park, MD</name_title>
    <organization>Samsung Medical Center, Seoul, Korea</organization>
  </responsible_party>
  <keyword>oxaliplatin</keyword>
  <keyword>neuropathy</keyword>
  <keyword>SNPs</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Oxaliplatin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

